29 South Greene Street, 217-A
Education and Training
- Tehran University of Medical Sciences, MD
- Johns Hopkins Bloomberg School of Public Health, MPH
- Detroit Medical Center/Wayne State University, Internship and Residency
- Johns Hopkins Hospital, Nephrology Training
- University of Maryland Medical Center, Fellowship, Transplant Nephrology
Dr. Haririan is a Professor of Medicine in the Division of Nephrology. He served as the medical director of the kidney and pancreas transplant program in Harper University Hospital in Detroit from 2001 to 2005, and then joined to transplant program at the University of Maryland Medical Center.
He is currently the Medical Director of the kidney and pancreas transplant programs and the Director of Transplant Nephrology Fellowship Training Program. He is serving on the editorial board of Clinical Nephrology and Transplantation journals and reviews manuscripts for close to 20 major journals, including the Journal of the American Society of Nephrology, the American Journal of Kidney Disease, the American Journal of Transplantation, and Transplantation.
Dr. Haririan is a member of numerous professional associations, including the American Society of Nephrology, the International Society of Nephrology, the American transplant Society and the Transplantation Society. His clinical interests include kidney and pancreas transplantation.
antibody-mediated graft injury in kidney transplantation, BK nephropathy, non-traditional risk factors for poor transplant outcomes, pancreas allograft rejection and optimization of immunosuppression, renal and transplant medicine, antibody-mediated rejection, Acthar, glomerulopathy.
Haririan A. Current status of the evaluation and management of antibody-mediated rejection in kidney transplantation. Curr Opin Nephrol Hypertens. 2015 Nov;24(6):576-81
Salzberg DJ, Karadsheh FF, Haririan A, Reddivari V, Weir MR. Specific management of anemia and hypertension in renal transplant recipients: influence of renin-angiotensin system blockade. Am J Nephrol. 2014;39(1):1-7.
Papadimitriou JC, Drachenberg CB, Ramos E, Kukuruga D, Klassen DK, Ugarte R, Nogueira J, Cangro C, Weir MR, Haririan A. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation. 2013 Jan 15;95(1):128-36.
Jones H, Talwar M, Nogueira JM, Ugarte R, Cangro C, Rasheed H, Klassen DK, Weir MR, Haririan A. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis. Transplantation. 2012 May 15;93(9):923-8.
Drachenberg CB, Torrealba JR, Nankivell BJ, Rangel EB, Bajema IM, Kim DU, Arend L, Bracamonte ER, Bromberg JS, Bruijn JA, Cantarovich D, Chapman JR, Farris AB, Gaber L, Goldberg JC, Haririan A, Honsová E, Iskandar SS, Klassen DK, Kraus E, Lower F, Odorico J, Olson JL, Mittalhenkle A, Munivenkatappa R, Paraskevas S, Papadimitriou JC, Randhawa P, Reinholt FP, Renaudin K, Revelo P, Ruiz P, Samaniego MD, Shapiro R, Stratta RJ, Sutherland DE, Troxell ML, Voska L, Seshan SV, Racusen LC, Bartlett ST. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant. 2011 Sep;11(9):1792-802
Haririan A, Metireddy M, Cangro C, Nogueira JM, Rasetto F, Cooper M, Klassen DK, Weir MR. Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis. Am J Transplant. 2011 Sep;11(9):1943-50.
Papadimitriou JC, Drachenberg CB, Munivenkatappa R, Ramos E, Nogueira J, Sailey C, Klassen DK,Haririan A. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation. 2010 Dec 27;90(12):1478-85.
Manitpisitkul W, Wilson NS, Haririan A. Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update. Expert Opin Drug Saf. 2010 Nov;9(6):959-69.
Haririan A, Nogueira JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, Klassen DK, Weir MR. The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation. 2010 Mar 15;89(5):573-9.
Haririan A, Kiangkitiwan B, Kukuruga D, Cooper M, Hurley H, Drachenberg C, Klassen D. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant. 2009 Dec;9(12):2758-67.
Manitpisitkul W, Drachenberg C, Ramos E, Munivenkatappa R, Philosophe B, Klassen D, Haririan A. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation. 2009 Jul 15;88(1):83-8.
Haririan A, Nogueira J, Kukuruga D, Schweitzer E, Hess J, Gurk-Turner C, Jacobs S, Drachenberg C, Bartlett S, Cooper M. Positive cross-match living donor kidney transplantation: longer-term outcomes. Am J Transplant. 2009 Mar;9(3):536-42.
Dr. Haririan’s clinical research interest is focused on antibody-mediated graft injury in kidney transplantation, BK nephropathy, non-traditional risk factors for poor transplant outcomes, pancreas allograft rejection and optimization of immunosuppression to improve long-term outcomes.
He has been the principal investigator for several investigator-initiated cohort studies and clinical trials. He has mentored a large number of residents, fellows, and junior faculty with interest in renal and transplant medicine. He has multiple ongoing studies examining the histological, serological, and clinical markers of antibody-mediated rejection and clinical management of patients with this complication.
Currently, Dr. Haririan is conducting a single-center clinical trial studying the use of Acthar for treatment of transplant glomerulopathy.
Kidney and pancreas transplantation, General nephrology